Fathers Day Facelift

•

0 likes•107 views

Barbara Corbett Au.D.

Still wondering what to get dad for father's day...how about a Facelift...

Health & Medicine

Recently uploaded

Young at heart: Cardiovascular health stations to empower healthy lifestyle b...

Catherine Liao

Ophthalmology Clinical Tests for OSCE exam

KafrELShiekh University

1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf

Ks doctor

"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...

Catherine Liao

TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th American Ed...

kevinkariuki227

basicmodesofventilation2022-220313203758.pdf

aljamhori teaching hospital

RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0). CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

Oleg Kshivets

Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...

Savita Shen $i11

Is preeclampsia and spontaneous preterm delivery associate with vascular and ...

Catherine Liao

DECIPHERING COMMON ECG FINDINGS IN ED.pptx

drwaque

For any queries ,contact shvmshrm@outlook.com --- ## Introduction to Eating Disorders Welcome to this comprehensive presentation on Eating Disorders, a critical and often misunderstood area of mental health. This presentation is designed to provide in-depth knowledge and insights into the various aspects of eating disorders, making it valuable for both postgraduate medical aspirants preparing for the INI-CET and the general public seeking to understand these complex conditions. ### Objectives: 1. **Understanding Eating Disorders**: Gain a clear understanding of what eating disorders are, their types, and their distinguishing characteristics. 2. **Etiology and Risk Factors**: Explore the underlying causes and risk factors that contribute to the development of eating disorders. 3. **Clinical Features and Diagnosis**: Learn about the clinical features, diagnostic criteria, and the importance of early detection. 4. **Management and Treatment**: Review the current approaches to managing and treating eating disorders, including medical, psychological, and nutritional interventions. 5. **Prevention and Awareness**: Discuss strategies for prevention, early intervention, and increasing awareness about eating disorders. This presentation aims to bridge the gap between academic knowledge and practical understanding, providing you with the tools to recognize, diagnose, and effectively manage eating disorders. Whether you are preparing for a medical exam or seeking to educate yourself or others about these serious conditions, this presentation will equip you with essential information and practical insights. Let's begin our journey into understanding eating disorders and the significant impact they have on individuals and society. --- For any queries ,contact shvmshrm@outlook.com

EATING DISORDERS (Psychiatry-7)by dr Shivam sharma.pptx

Shivam Sharma

These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram. Learning objectives: 1. Define an electrocardiogram (ECG) and electrocardiography 2. Describe how dipoles generated by the heart produce the waveforms of the ECG 3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II) 4. Differentiate between intervals and segments 5. Enlist some common indications for obtaining an ECG Study Resources: 1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition 2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition 3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition 4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/ 5. ECG in Medical Practice by ABM Abdullah, 4th edition 6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics

The Normal Electrocardiogram - Part I of II

MedicoseAcademics

Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol that is rapidly distributed in the body and brain. Ethanol alters many neurochemical systems and has rewarding and addictive properties. It is the oldest recreational drug and likely contributes to more morbidity, mortality, and public health costs than all illicit drugs combined. The 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) integrates alcohol abuse and alcohol dependence into a single disorder called alcohol use disorder (AUD), with mild, moderate, and severe subclassifications (American Psychiatric Association, 2013). In the DSM-5, all types of substance abuse and dependence have been combined into a single substance use disorder (SUD) on a continuum from mild to severe. A diagnosis of AUD requires that at least two of the 11 DSM-5 behaviors be present within a 12-month period (mild AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria). The four main behavioral effects of AUD are impaired control over drinking, negative social consequences, risky use, and altered physiological effects (tolerance, withdrawal). This chapter presents an overview of the prevalence and harmful consequences of AUD in the U.S., the systemic nature of the disease, neurocircuitry and stages of AUD, comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and pharmacotherapies for AUD.

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf

Dr Jeenal Mistry

i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource. This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and Associate Division Director for Ambulatory Operations The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma. STATEMENT OF NEED Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL. Target Audience Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL). Learning Objectives 1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL 2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults 3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

i3 Health

Gauri Gawande(9) Constipation Final.pptx

gauripg8

Relationship between vascular system disfunction, neurofluid flow and Alzheim...

Catherine Liao

How to Give Better Lectures: Some Tips for Doctors

LanceCatedral

1. DELIVERY OF HEALTH CARE SERVICES IN RURAL.ppt

pooja kajla

Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx

gauripg8

Antiplatelets in IHD, Dose Duration, DAPT vs SAPT

AkashGanganePatil1

Recently uploaded (20)

Young at heart: Cardiovascular health stations to empower healthy lifestyle b...

Ophthalmology Clinical Tests for OSCE exam

1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf

"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...

TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th American Ed...

basicmodesofventilation2022-220313203758.pdf

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...

Is preeclampsia and spontaneous preterm delivery associate with vascular and ...

DECIPHERING COMMON ECG FINDINGS IN ED.pptx

EATING DISORDERS (Psychiatry-7)by dr Shivam sharma.pptx

The Normal Electrocardiogram - Part I of II

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

Gauri Gawande(9) Constipation Final.pptx

Relationship between vascular system disfunction, neurofluid flow and Alzheim...

How to Give Better Lectures: Some Tips for Doctors

1. DELIVERY OF HEALTH CARE SERVICES IN RURAL.ppt

Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx

Antiplatelets in IHD, Dose Duration, DAPT vs SAPT

Fathers Day Facelift

Recommended

Recommended

More Related Content

More from Barbara Corbett Au.D.

More from Barbara Corbett Au.D. (14)

Recently uploaded

Recently uploaded (20)